Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R L Bell

Showing results (121-130 of 148) with videos related to

Pageof 15
Sort By:
Clinical Pharmacology and Therapeutics|March 27, 2015
Understanding Disease-Drug Interactions in Cancer Patients: Implications for Dosing Within the Therapeutic WindowD E Coutant, P Kulanthaivel, P K Turner, et al.
Journal of Medicinal Chemistry|July 1, 1991
4-hydroxythiazole inhibitors of 5-lipoxygenaseF A Kerdesky, J H Holms, J L Moore, et al.
British Journal of Cancer|June 5, 2003
Cooperative effects of matrix metalloproteinase and cyclooxygenase-2 inhibition on intestinal adenoma reductionR A Wagenaar-Miller, G Hanley, R Shattuck-Brandt, et al.
Alcoholism, Clinical and Experimental Research|August 16, 2001
Effects of concurrent access to multiple ethanol concentrations and repeated deprivations on alcohol intake of alcohol-preferring ratsZ A Rodd-Henricks, R L Bell, K A Kuc, et al.
Peptides|August 24, 1999
Tyr-W-MIF-1-induced conditioned place preferenceW L Nores, R D Olson, G A Olson, et al.
JPEN. Journal of Parenteral and Enteral Nutrition|July 1, 1986
Total parenteral nutrition-related cholestasis in infantsR L Bell, G D Ferry, E O Smith, et al.
Annals of the New York Academy of Sciences|November 30, 1993
Preclinical and clinical activity of zileuton and A-78773R L Bell, C Lanni, P E Malo, et al.
Journal of Lipid Mediators|March 1, 1993
A-78773: a selective, potent 5-lipoxygenase inhibitorR L Bell, D W Brooks, P R Young, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1991
5-lipoxygenase inhibitory activity of zileutonG W Carter, P R Young, D H Albert, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1997
Induction of prostaglandin H synthase-2 and tumor necrosis factor-alpha in human amnionic WISH cells by various stimuli occurs through distinct intracellular mechanismsK I Hulkower, E R Otis, J Li, et al.
Pageof 15

Showing results (121-130 of 148) with videos related to

Sort By:
Pageof 15
Clinical Pharmacology and Therapeutics|March 27, 2015
Understanding Disease-Drug Interactions in Cancer Patients: Implications for Dosing Within the Therapeutic WindowD E Coutant, P Kulanthaivel, P K Turner, et al.
Journal of Medicinal Chemistry|July 1, 1991
4-hydroxythiazole inhibitors of 5-lipoxygenaseF A Kerdesky, J H Holms, J L Moore, et al.
British Journal of Cancer|June 5, 2003
Cooperative effects of matrix metalloproteinase and cyclooxygenase-2 inhibition on intestinal adenoma reductionR A Wagenaar-Miller, G Hanley, R Shattuck-Brandt, et al.
Alcoholism, Clinical and Experimental Research|August 16, 2001
Effects of concurrent access to multiple ethanol concentrations and repeated deprivations on alcohol intake of alcohol-preferring ratsZ A Rodd-Henricks, R L Bell, K A Kuc, et al.
Peptides|August 24, 1999
Tyr-W-MIF-1-induced conditioned place preferenceW L Nores, R D Olson, G A Olson, et al.
JPEN. Journal of Parenteral and Enteral Nutrition|July 1, 1986
Total parenteral nutrition-related cholestasis in infantsR L Bell, G D Ferry, E O Smith, et al.
Annals of the New York Academy of Sciences|November 30, 1993
Preclinical and clinical activity of zileuton and A-78773R L Bell, C Lanni, P E Malo, et al.
Journal of Lipid Mediators|March 1, 1993
A-78773: a selective, potent 5-lipoxygenase inhibitorR L Bell, D W Brooks, P R Young, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1991
5-lipoxygenase inhibitory activity of zileutonG W Carter, P R Young, D H Albert, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1997
Induction of prostaglandin H synthase-2 and tumor necrosis factor-alpha in human amnionic WISH cells by various stimuli occurs through distinct intracellular mechanismsK I Hulkower, E R Otis, J Li, et al.
Pageof 15